Cargando…

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

BACKGROUND: Acute vulvovaginal candidiasis (VVC) is common among women, but current azole antifungal treatments are often associated with safety and resistance issues. VT-1161 (oteseconazole) is an oral agent with increased selectivity for fungal CYP51. In this phase 2 clinical study, we evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brand, Stephen R, Sobel, Jack D, Nyirjesy, Paul, Ghannoum, Mahmoud A, Schotzinger, Robert J, Degenhardt, Thorsten P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492116/ https://www.ncbi.nlm.nih.gov/pubmed/32818963 http://dx.doi.org/10.1093/cid/ciaa1204

Ejemplares similares

107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet)
por: Martens, Mark G, et al.
Publicado: (2021)

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)
por: Sobel, R, et al.
Publicado: (2021)

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)
por: Schwebke, Jane R, et al.
Publicado: (2021)

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
por: Yano, Junko, et al.
Publicado: (2019)

Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
por: Goje, Oluwatosin, et al.
Publicado: (2023)

VT-1161—A Tetrazole for Management of Mono- and Dual-Species Biofilms
por: Maione, Angela, et al.
Publicado: (2023)

Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
por: Sobel, Jack D
Publicado: (2013)

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
por: Thompson, George R, et al.
Publicado: (2020)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study
por: Muzny, Christina A, et al.
Publicado: (2021)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice
por: Break, Timothy J, et al.
Publicado: (2017)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Clinical and morphopathological assay in vulvovaginal candidiasis
por: Manolea, Maria Magdalena, et al.
Publicado: (2022)

Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023)

In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
por: Sobel, Jack D., et al.
Publicado: (2021)

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
por: Rosentul, Diana C., et al.
Publicado: (2014)

Vulvovaginal Trichosporonosis
por: Makela, Paul, et al.
Publicado: (2003)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
por: Mahmoudabadi, Ali Zarei, et al.
Publicado: (2013)

Sexual function, depression, anxiety, and vulvovaginal candidiasis
por: Başer, Emre, et al.
Publicado: (2021)

Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study
por: Moreau, Philippe, et al.
Publicado: (2021)

A Role for Yeast/Pseudohyphal Cells of Candida albicans in the Correlated Expression of NLRP3 Inflammasome Inducers in Women With Acute Vulvovaginal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019)

Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1994)

Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
por: Woodburn, Kathryn W., et al.
Publicado: (2019)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
por: Willems, Hubertine M. E., et al.
Publicado: (2020)

Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
por: Rodríguez-Cerdeira, Carmen, et al.
Publicado: (2020)

Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus
por: Phillips, Nancy A., et al.
Publicado: (2022)

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022)

Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics
por: Maftei, Nicoleta-Maricica, et al.
Publicado: (2023)

DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study
por: Chemaly, Roy F, et al.
Publicado: (2021)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
por: Johannsson, Gudmundur, et al.
Publicado: (2020)

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)
por: Overcash, J Scott, et al.
Publicado: (2020)

Kinetics and Interrelations of the Renin Aldosterone Response to Acute Psychosocial Stress: A Neglected Stress System
por: Gideon, Angelina, et al.
Publicado: (2019)

Fibroblast Growth Factor-21, Leptin, and Adiponectin Responses to Acute Cold-Induced Brown Adipose Tissue Activation
por: Sun, Lijuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9o5fii4metju78pcu62tdj0d5d